

Program
Wednesday 4 November
Evening
Thursday 5 November - Open scientific meeting (no registration fee)
Auditorium - Institute for Cancer Research, Radium Hospital
07:45 - 08:15
08:15 - 08:30
08:30 - 09:00
Session 1: Multimodal diagnostics
Chair: TBA
09:00 - 09:20
09:20 - 09:40
09:40 - 09:55
09:55 - 10:10
10:10 - 10:30
Session 2: Digital pathology meets spatial biology
Chair: TBA
10:30 - 10:50
10:50 - 11:05
11:05 - 11:20
11:20 - 11:35
11:35 - 11:50
11:50 - 12:20
12:30 - 13:30
13:30 - 13:40
13:40 - 14:10
Session 3: Dynamic/longitudinal diagnostics
Chair: TBA
14:10 - 14:30
14:30 - 14:45
14:45 - 15:00
15:00 - 15:15
15:15 - 15:35
Session 4: Functional diagnostics - integrated into pathology
Chair: TBA
15:40 - 16:00
16:00 - 16:20
16:20 - 16:35
16:35 - 16:50
16:50 - 17:05
17:05 - 17:30
Aftermath for speakers/invited/organisers: Bus trip – see Oslo: The Munch Museum - snack food and drinks, dinner Villa Ekebakken 19.30
Friday 6 November - Only invited, Villa Ekebakken: Expert opinion discussions
The same 4 topics for group discussions as lectured the 1st day.
Chairs: Intro from 1st day with open questions.
What is ready for implementation in diagnostics? Pros and cons for benefit.
How to strengthen novel clinical studies?
Get together and dinner for guests/organizers, Villa Ekebakken
Registration, poster setup, and coffee
Welcome address. Jan Vincents Johannessen
Manuel Sobrinho Simões honorary lecture. Hege E. G. Russnes. A Legacy of Excellence in Onco-Pathology Research, Education, and Leadership
Albrect Stenzinger, University Hospital Heidelberg
Noel de Miranda, Leiden University Medical Center
TBA
Q&A
Coffee break
Catarina Eloy, IPATIMUP-i3S Porto
Raza Ali, CRUK Cambridge Institute
Margareta Correia, IPO-Porto
TBA
Q&A
Selected abstracts for oral presentations from Session 1 and 2.
Lunch bags and Poster Session (Open space by the cantina)
Presentation of the Jan Vincents Johannessen Award winner. Sigbjørn Smeland
The Jan Vincents Johannessen Award lecture.
TBA
Guro E. Lind, Institute for Cancer Research, OUS: "Urine biomarker-based monitoring of bladder cancer"
Manuel R. Teixeira
Q&A
Short coffee break
TBA
TBA
Jorge Lima, IPATIMUP/i3S: "Patient-derived tumoroids as a drug screening platform for pediatric brain tumors"
Kushtrim Kryeziu, Institute for Cancer Research, OUS: "Modeling therapy response and resistance in patient derived organoids from colorectal cancer"
Q&A
Selected abstracts for oral presentations from Session 3 and 4.